A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.
about
A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@ast
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@en
type
label
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@ast
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@en
prefLabel
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@ast
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@en
P2093
P2860
P1476
A pharmacoeconomic analysis of ...... beractant, or poractant alfa.
@en
P2093
Carlos G Guardia
Fernando R Moya
Jay S Greenspan
Phillip D Simmons
Robert Segal
Sunil Sinha
P2860
P304
P356
10.5863/1551-6776-17.3.220
P577
2012-07-01T00:00:00Z